Coulter-Mackie M B, Gagnier L, Beis M J, Applegarth D A, Cole D E, Gordon K, Ludman M D
Department of Pediatrics, University of British Columbia, Vancouver, Canada.
J Med Genet. 1997 Jun;34(6):493-8. doi: 10.1136/jmg.34.6.493.
Metachromatic leucodystrophy (MLD) is a lysosomal storage disease resulting from a deficiency of arylsulphatase A. We have identified a child with infantile onset MLD who is homozygous for an A212V mutation, a mutation previously reported but not further characterised. We have introduced this mutation into an arylsulphatase A expression vector by site directed mutagenesis. Transient expression of this mutant plasmid in COS cells yields very low levels of arylsulphatase A activity consistent with the patient's phenotype. The arylsulphatase A pseudodeficiency also segregates in this family causing difficulty in interpreting enzyme levels in the absence of DNA data. Two other patients from the same province, also carrying the A212V allele, have juvenile and adult onset MLD and are heterozygous for P426L ("A" allele) and I179S alleles respectively, known late onset alleles.
异染性脑白质营养不良(MLD)是一种由于芳基硫酸酯酶A缺乏导致的溶酶体贮积病。我们鉴定出一名患有婴儿型MLD的儿童,其为A212V突变的纯合子,该突变先前已有报道但未进一步表征。我们通过定点诱变将此突变引入芳基硫酸酯酶A表达载体。该突变体质粒在COS细胞中的瞬时表达产生的芳基硫酸酯酶A活性水平极低,这与患者的表型一致。芳基硫酸酯酶A假缺陷在这个家族中也呈分离状态,这使得在没有DNA数据的情况下难以解释酶水平。来自同一省份的另外两名患者也携带A212V等位基因,分别患有青少年型和成人型MLD,并且分别是已知的迟发型等位基因P426L(“A”等位基因)和I179S等位基因的杂合子。